Abstract
The confirmed number of SARS-CoV-2 infections up to 30 August 2021 is 217 mil. worldwide but information about factors affecting the probability of infection or of a severe course of Covid-19 remains insufficient and often speculative. Only a small number of factors have been rigorously examined, mostly by retrospective or cross-sectional studies. We ran a preregistered study on 5,164 internet users who shared with us information about their exposure to 105 risk factors and reported being Covid negative before the beginning of the fourth wave of Covid-19 in the Czech Republic. After the fourth wave, in which 709 (13.7%) of participants were infected, we used a partial Kendall test controlled for sex, age, and urbanisation to compare the risk of infection and of a severe course of the disease in subjects who originally did and did not report exposure to particular risk factors. After the correction for multiple tests, we identified 13 factors – including male sex, lower age, blood group B, and the larger household size – that increased the risk of infection and 16 factors – including mask wearing, borreliosis in the past, use of vitamin D supplements, or rooibos drinking – that decreased it. We also identified 23 factors that increased the risk of a severe course of Covid-19 and 12 factors that decreased the risk.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by Czech Science Foundation, grant number 18-13692S.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data collection was performed in accordance with all relevant guidelines and regulations and the project, including the method of obtaining informed consent with participation in this anonymous study from all participants, was approved by the Institutional Review Board of the Faculty of Science, Charles University (Komise pro praci s lidmi a lidskym materialem Prirodovedecke Fakulty Univerzity Karlovy) - No. 2020/25)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are available at Figshare 10.6084/m9.figshare.16529184
